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The ability of the death ligand TRAIL to induce tumor cell apoptosis has led to the development of TRAIL-
based cancer therapies. Reporting recently in Molecular Cell, Lu et al. (2014) show that the basis for
differential TRAIL responses involves clustering of death receptor complexes by E-cadherin and the actin
cytoskeleton.Apoptosis can be triggered by cell-
intrinsic pathways or through soluble
extracellular ligands in the tumor necrosis
factor (TNF) family (LeBlanc and Ashke-
nazi, 2003). The death ligand Apo2L/
TRAIL displays the unique ability to differ-
entially induce apoptosis of many types of
cancer cells. This property of TRAIL moti-
vated the development of TRAIL-receptor
agonists as cancer therapeutics. While
these agonists showed promise in pre-
clinical studies, they have not performed
well in the clinic (Stuckey and Shah,
2013). A recent report by Lu et al. (2014),
published in Molecular Cell, describes a
cellular mechanism whereby cells can
escape TRAIL-induced death. Studies in
this report show that TRAIL receptors
couple to E-cadherin, which promotes re-
ceptor clustering and formation of active
TRAIL signaling complexes through link-
age with the actin cytoskeleton. Loss
of E-cadherin, e.g., through epithelial-
mesenchyme transition (EMT), protects
cells from TRAIL-induced death (Lu
et al., 2014). These findings reveal impor-
tant mechanistic insights into the basis for
differential sensitivity to TRAIL that can be
exploited therapeutically.
E-cadherin is a transmembrane protein
that links epithelial cells at adherens
junctions. Loss of E-cadherin, via methyl-
ation, mutation, deletion, or transcrip-
tional downregulation by EMT-promoting
factors, is a common occurrence in
many cancers (Jeanes et al., 2008).
Mounting evidence indicates that EMT
promotes resistance to anticancer thera-
pies (Tiwari et al., 2012); however, the
mechanisms underlying resistance are
not well understood. Through investiga-tions triggered by evidence that EMT pro-
motes resistance to apoptosis induced by
the TNF ligand Apo2L/TRAIL, the authors
found that loss of E-cadherin in epithelial
cells is sufficient to induce TRAIL resis-
tance. Conversely, specific E-cadherin
ligation by culturing cells on plates coated
with the extracellular domain of E-cad-
herin enhanced TRAIL-induced apoptosis
(Lu et al., 2014). This effect was specific
to TRAIL-induced apoptosis, because
alterations in E-cadherin did not affect
apoptosis induced by another death
ligand, FasL, which operates through
different receptors. Thus, E-cadherin
adhesions sensitize some cancer cells to
death induced by TRAIL.
Interestingly, the authors found that
E-cadherin is associated in a complex
with DR4 and DR5. This connection de-
pends on TRAIL engagement of the re-
ceptor and, furthermore, occurs via the
EC1 extracellular domain of E-cadherin
and requires Ca2+, indicating that the
heterotypic interaction between the re-
ceptors and E-cadherin has similar re-
quirements as the homotypic interactions
between E-cadherin molecules (Lu et al.,
2014). Cell-cell adhesion is also regulated
by dynamic coupling to the actin cyto-
skeleton, which strengthens E-cadherin-
mediated adhesion through actomyosin
contractility (Huveneers and de Rooij,
2013). The authors found that TRAIL-
induced apoptosis and the formation of
active death-inducing signaling com-
plexes (DISCs) are dependent on both
actin polymerization and a-catenin, which
links E-cadherin to the actin cytoskel-
eton. This provides key information indi-
cating that the actin cytoskeletal linkageDevelopmental Cthrough E-cadherin/a-catenin is critical
for efficient assembly of active death
complexes (Lu et al., 2014). Interestingly,
FAS links to the actin cytoskeleton
through Ezrin, and this interaction regu-
lates FAS-induced apoptosis, suggesting
that different death receptors may co-opt
distinct cytoskeleton-coupling protein
complexes to control clustering (Desouza
et al., 2012).
Clustering of death receptors into a
DISC is a well-characterized process
that is critical for the execution of
apoptosis. The formation of the DISC is
initiated by the recruitment of FADD and
caspase-8. Further oligomerization and
cleavage of caspase-8 is central to its
maximal activation and the subsequent
downstream activation of executioner
caspases to orchestrate apoptotic death
(Dickens et al., 2012). Other molecules
are also recruited to the DISC to regulate
apoptosis, including cFLIPs, which can
have both inhibitory and enhancing
effects on apoptosis, and the E3 ligase
cullin-3, which ubiquitinates caspase-8
to further promote clustering and activa-
tion of the DISC (Dickens et al., 2012).
The incorporation of DR4 and DR5 into
E-cadherin adhesion structures, harness-
ing the clustering power driven by acto-
myosin contractility, is an effective way
to facilitate assembly of the DISC. This
enables lower concentrations of TRAIL
to achieve full caspase activation and
leads to enhanced cell death (Lu et al.,
2014). It is interesting to note that two
decoy receptors exist for TRAIL—DcR1
and DcR2—and they can influence death
receptor signaling and, because of their
high degree of similarity to DR4 andell 30, July 14, 2014 ª2014 Elsevier Inc. 3
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with E-cadherin. DcR1 and DcR2 lack an
intracellular death domain and function
to suppress apoptosis (LeBlanc and
Ashkenazi, 2003). Thus, it will be impor-
tant to determine whether these decoy re-
ceptors can bind E-cadherin and whether
their expression regulates the extent
to which E-cadherin adhesion facilitates
TRAIL-induced apoptosis.
In addition to examining whether
E-cadherin interacts with decoy death
receptors, it is also of interest to test
whether other cadherins (e.g., P-, VE-,
and N-cadherins) can interact with and
augment the functions of death and/or
decoy receptors. This is especially rele-
vant in the case of EMT, in which an in-
crease in N-cadherin expression often
accompanies a decrease in E-cadherin
(i.e., ‘‘cadherin switch’’) (Tiwari et al.,
2012), yet the cells remain resistant to
TRAIL (Lu et al., 2014). Is N-cadherin un-
able to bind to DR4/5 or is the linkage
ineffective in linking to the cytoskeleton?
Additionally, these results raise the ques-
tion of whether TRAIL-induced clustering4 Developmental Cell 30, July 14, 2014 ª201of the DISC with E-cadherin has any ef-
fect on the stability of cell-cell adhesions
during programmed cell death. For
example, does the assembly of the
DISC with E-cadherin adhesions recruit
caspases or E3 ligases to target adhe-
sion proteins for degradation as part of
the apoptotic cascade? Future studies
investigating these possibilities will
further characterize the crosstalk be-
tween cell-cell adhesion and death re-
ceptor-induced apoptosis in normal and
cancer cells.
Because TRAIL has strong antitumor
activity in many cancer cell lines but has
limited effects in many normal cell types,
preclinical and clinical trials for agents
that trigger TRAIL-induced apoptosis
were widely explored for the treatment
of solid tumors and hematological malig-
nancies. These efforts have largely been
unsuccessful in a clinical setting, although
positive responses in some patients hint
that this strategy deserves further explo-
ration (Stuckey and Shah, 2013). The find-
ings from this new study and additional
investigations into cadherin-death recep-4 Elsevier Inc.tor interactions will provide important in-
sights relevant to further development
of TRAIL-based anticancer therapeutics
and for the identification of biomarkers
that will predict the efficacy of these treat-
ment strategies.
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Reporting inCell, Li and colleagues (2014) describe an innovative method to functionally classify genes using
evolutionary information. This approach demonstrates broad utility for eukaryotic gene annotation and sug-
gests an intriguing new decomposition of pathways and complexes into evolutionarily conserved modules.Recent efforts in genome sequencing
have generated a substantial catalog
of complete genome sequences. This
growing data set now affords us a major
opportunity: to map the evolutionary and
functional relationships between genes
by carrying out a statistical comparison
of genomic content across species. In
1999, Pellegrini and coworkers described
one conceptually simple but powerfulstrategy for doing exactly this (Pellegrini
et al., 1999). Their idea was to infer protein
interactions from the concerted loss (or
gain) of genes across species. Groups of
genes with similar patterns of presence
and absence might reflect the influence
of some common selective constraint,
providing an evolutionary indication that
the collective activity of the gene group
is relevant for function. In the originalmethod, termed ‘‘phylogenetic profiling,’’
each gene is described by a binary vector
(or profile) indicating presence (‘‘1’’) or
absence (‘‘0’’) across all sequenced ge-
nomes. The evolutionary similarity be-
tween a pair of genes is then measured
by the number of ones or zeroes differing
between the two vectors, an information-
theoretic quantity termed the Hamming
distance. It was shown that genes with
